Cargando…

KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM)

Malignant pleural mesothelioma (MPM) is a rare and incurable cancer, which incidence is increasing in many countries. MPM escapes the classical genetic model of cancer evolution, lacking a distinctive genetic fingerprint. Omics profiling revealed extensive heterogeneity failing to identify major vul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorenzini, Eugenia, Torricelli, Federica, Zamponi, Raffaella, Donati, Benedetta, Manicardi, Veronica, Sauta, Elisabetta, Faria do Valle, Italo, Reggiani, Francesca, Gugnoni, Mila, Manzotti, Gloria, Fragliasso, Valentina, Vitale, Emanuele, Piana, Simonetta, Sancisi, Valentina, Ciarrocchi, Alessia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Cancer Gene Regulation, Chromatin, and Epigenetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336180/ https://www.ncbi.nlm.nih.gov/pubmed/35910692 http://dx.doi.org/10.1093/narcan/zcac024

Ejemplares similares

HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms
por: Manzotti, Gloria, et al.
Publicado: (2019)

OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer
por: Gugnoni, Mila, et al.
Publicado: (2022)

A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2
por: Vitale, Emanuele, et al.
Publicado: (2022)

Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer
por: Gugnoni, Mila, et al.
Publicado: (2016)

Adding pieces to the puzzle of differentiated-to-anaplastic thyroid cancer evolution: the oncogene E2F7
por: Gugnoni, Mila, et al.
Publicado: (2023)

Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapy
por: Torricelli, F, et al.
Publicado: (2023)

RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN
por: Sancisi, Valentina, et al.
Publicado: (2017)

The DNA-helicase HELLS drives ALK(−) ALCL proliferation by the transcriptional control of a cytokinesis-related program
por: Tameni, Annalisa, et al.
Publicado: (2021)

The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1
por: Gallo, Cristina, et al.
Publicado: (2018)

An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer Metastatization
por: Torricelli, Federica, et al.
Publicado: (2023)

Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas
por: Gandolfi, Greta, et al.
Publicado: (2017)

Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy
por: Manzotti, Gloria, et al.
Publicado: (2019)

Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
por: Pagano, Maria, et al.
Publicado: (2020)

KAP1 facilitates reinstatement of heterochromatin after DNA replication
por: Jang, Suk Min, et al.
Publicado: (2018)

An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma
por: Reggiani, Francesca, et al.
Publicado: (2021)

Molecular Fingerprints of Malignant Pleural Mesothelioma: Not Just a Matter of Genetic Alterations
por: Lorenzini, Eugenia, et al.
Publicado: (2021)

Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphoma
por: Mularoni, Valentina, et al.
Publicado: (2023)

No Need to Stick Together to Be Connected: Multiple Types of Enhancers’ Networking
por: Vitale, Emanuele, et al.
Publicado: (2021)

Malignant Pleural Mesothelioma (MPM) Presenting as Hydropneumothorax
por: Kuramochi, Masami, et al.
Publicado: (2023)

CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer
por: Sauta, Elisabetta, et al.
Publicado: (2021)

BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells
por: Rossi, Teresa, et al.
Publicado: (2023)

Phosphorylation of the HP1β hinge region sequesters KAP1 in heterochromatin and promotes the exit from naïve pluripotency
por: Qin, Weihua, et al.
Publicado: (2021)

The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling
por: Gobbi, Giulia, et al.
Publicado: (2023)

Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer
por: Gugnoni, Mila, et al.
Publicado: (2019)

Deep Sequencing Analysis Identified a Specific Subset of Mutations Distinctive of Biphasic Malignant Pleural Mesothelioma
por: Torricelli, Federica, et al.
Publicado: (2020)

Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment
por: Gounant, Valérie, et al.
Publicado: (2021)

Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer
por: Ragazzi, Moira, et al.
Publicado: (2014)

Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)
por: Klampatsa, Astero, et al.
Publicado: (2017)

Cadherin 6 Is a New RUNX2 Target in TGF-β Signalling Pathway
por: Sancisi, Valentina, et al.
Publicado: (2013)

Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM)
por: Wright, Casey M., et al.
Publicado: (2013)

The Role of E-Cadherin and microRNA on FAK Inhibitor Response in Malignant Pleural Mesothelioma (MPM)
por: Yuen, Man Lee, et al.
Publicado: (2021)

Cytoskeleton Dynamics in Peripheral T Cell Lymphomas: An Intricate Network Sustaining Lymphomagenesis
por: Fragliasso, Valentina, et al.
Publicado: (2021)

Alternative splicing analysis in human monocytes and macrophages reveals MBNL1 as major regulator
por: Liu, Hongfei, et al.
Publicado: (2018)

Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM)
por: Lapidot, Moshe, et al.
Publicado: (2021)

Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing
por: Laure, Alexander, et al.
Publicado: (2023)

Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients
por: Cedres, Susana, et al.
Publicado: (2023)

c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer
por: Caggiano, Cinzia, et al.
Publicado: (2019)

Identification of RNA polymerase III-transcribed Alu loci by computational screening of RNA-Seq data
por: Conti, Anastasia, et al.
Publicado: (2015)

CDK12/13 promote splicing of proximal introns by enhancing the interaction between RNA polymerase II and the splicing factor SF3B1
por: Panzeri, Valentina, et al.
Publicado: (2023)

MA04.07 Clinical Characteristics and Outcomes in Patients With Malignant Pleural Mesothelioma (MPM) with COVID-19 Infection
por: Cedres, S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qrrvpv97kjkmbq28onkeh2sk5d